[ET Net News Agency, 24 March 2022] SINO BIOPHARM (01177) rose 2.82% to HK$5.1.
It hits an intra-day high of HK$5.11, and an intra-day low of HK$4.88. The total shares
traded was 30.23 million, with a value of HK$151.54m. The active buy/sell ratio is 56:44,
with net buying turnover of HK$17.36m. UBS SEC accounts for greatest net responsive buying
turnover of HK$12.13m, with volume weighted average price of HK$5.01. MORGAN STANLEY HK
SEC accounts for greatest net responsive selling turnover of HK$10.71m, with volume
weighted average price of HK$5.036. The stock has risen a combined 10.87% over the past 4
consecutive trading days.
The Hang Seng Index now rose 6 points, or 0.03% to 22,160; the Hang Seng China
Enterprises Index now rose 6 points, or 0.09% to 7,642; the Hang Seng TECH Index now fell
23 points, or 0.49% to 4,725; with an overall turnover of HK$75.52b.
The SSE Composite Index now fell 17 points, or 0.54% to 3,253, with an overall turnover
of RMB240.29b.
The SZSE Component Index now fell 115 points, or 0.93% to 12,292, with an overall
turnover of RMB125.51b.

Basic Information
=================

----------------------------------
Nominal 5.100 % Chg +2.82%
High 5.110 Low 4.880
Shares Tr 30.23m Turnover 151.54m
10-D SMA 4.507 %H.V 76.525
20-D SMA 4.598 VWAP 5.013
50-D SMA 5.243 RSI14 57.342
----------------------------------
Status: Active buy/sell ratio is 56:44, with net buying turnover of HK$17.36m, rising a
combined 10.87% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
----------------------------------------------
SINO BIOPHARM (01177) 5.10 +2.82
SIHUAN PHARM (00460) 1.76 +2.92
CMS (00867) 13.14 +1.86
CSPC PHARMA (01093) 9.31 +1.53
SIMCERE PHARMA (02096) 11.28 +2.17
FOSUN PHARMA (02196) 37.40 +4.62
WUXI APPTEC (02359) 129.70 +3.93
SH PHARMA (02607) 16.06 +4.42
HANSOH PHARMA (03692) 16.46 +0.98
PHARMARON (03759) 95.05 +3.09
----------------------------------------------
(ed)